Jason Deleon
Family Medicine · New Orleans, LANPI 1497073787
Payments from drug & device makers
Across 223 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$498
- Pfizer$391
- Gilead$266
- GSK$229
- Genentech USA, Inc.$133
- plus $575 from 14 others
What the payments were for
- Food & beverage$3,625100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 98 | $1,534 |
| Lilly USA, LLC | 31 | $498 |
| Pfizer | 29 | $391 |
| Gilead | 10 | $266 |
| GSK | 13 | $229 |
| Genentech USA, Inc. | 9 | $133 |
| AstraZeneca | 5 | $99 |
| Biohaven Pharmaceuticals, Inc. | 5 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Novartis | 4 | $70 |
| Bayer | 3 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $47 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Braeburn Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Qiagen, LLC | 1 | $13 |
| Orexo US, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Truvada$118
How this compares
$3,625 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyproheptadine Hcl | 12 | $731 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 15 | $210 |
| Gabapentin | 12 | $115 |
| Atorvastatin Calcium | 24 | $112 |
| Amlodipine Besylate | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Other family medicine in New Orleans
- Stephen JonesNew Orleans$513K
- Kristen ThomasNew Orleans$361K
- Ibrahim ZeinatyNew Orleans$13K
- Clinton GuilloryMonroe$18.5M
- Jason MorrisLake Charles$18M
- Michael SeepLake Charles$9.1M
- William NaboursLake Charles$3M
- Ramon VargasKenner$2.1M
- Joshua WhatleyLake Charles$366K
- Richard JeansonneMandeville$362K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.